收藏切换
Optimization of preparation process and in vitro evaluation of parthenolide liposomes
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(8) : 2799 - 2810
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(8): 2799-2810
Optimization of preparation process and in vitro evaluation of parthenolide liposomes
Full
QIU Weian1, LU Guangzhao2, YU Qianxue2, HUANG Yanqiu1, HE Yongping1, ZHU Yu1, ZHANG Yuyan1, YE Yong1,3, LIU Yue2,4
Affiliations
    1 College of Pharmacy, Guangxi Medical University, Nanning 530021, China;
    2 School of Pharmacy, Naval Medical University, Shanghai 200433, China;
    3 Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Nanning 530021, China;
    4 Shanghai Key Laboratory for Pharmaceutical Metabolite Research, Shanghai 200433, China
doi: 10.7501/j.issn.0253-2670.2025.08.016
Outline
收藏切换
Objective To optimize the formulation of parthenolide liposomes (Par-Lips) by Box-Behnken design-response surface method (BBD-RSM), and to characterize its quality and evaluate its efficacy in vitro. Methods Par-Lips was prepared by the thin-film hydration method. The encapsulation efficiency, drug loading, ζ potential, particle size and PDI were investigated. The formulation of Par-Lips was optimized through single factor and BBD-RSM, and the formulation of Par-Lips was evaluated. At the same time, CCK-8 assay was used to investigate its in vitro efficacy on bile duct cancer TFK-1 cells. Results The optimum formulation of Par-Lips was 68.68 mg of DSPE-PEG2000, the ratio of membrane to material was 150:1 and the ratio of drug to lipid was 1:10.15. The encapsulation efficiency of Par-Lips was (83.18 ±0.90) %, the drug loading was (5.87 ±0.06) %, the ζ potential was (−7.36 ±0.02) mV, the particle size was (67.38 ±0.33) nm, and the PDI was 0.200 ±0.003. The release of Par-Lips in vitro has a certain sustained release effect compared with parthenolide. The results of antitumor activity in vitro showed that compared with parthenolide solution, Par-Lips significantly inhibited the growth of bile duct cancer TFK-1 cells in vitro (P < 0.001). Conclusion The optimal formulation process of Par-Lips was obtained by BBD-RSM. The preparation has uniform particle size, good stability, sustained release and can significantly inhibit the growth of bile duct cancer TFK-1 cells.
parthenolide  /  liposome  /  cholangiocarcinoma  /  cytotoxicity  /  Box-Behnken design-response surface method  /  thin-film hydration method  /  pharmaceutics  /  CCK-8 assay  /  antitumor
丘炜桉, 卢光照, 俞千雪, 黄艳秋, 何永平, 朱煜, 张裕彦, 叶勇, 刘悦. 小白菊内酯脂质体的制备工艺优化及体外评价. 中草药, 2025 , 56 (8) : 2799 -2810 . DOI: 10.7501/j.issn.0253-2670.2025.08.016
QIU Weian, LU Guangzhao, YU Qianxue, HUANG Yanqiu, HE Yongping, ZHU Yu, ZHANG Yuyan, YE Yong, LIU Yue. Optimization of preparation process and in vitro evaluation of parthenolide liposomes[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (8) : 2799 -2810 . DOI: 10.7501/j.issn.0253-2670.2025.08.016
Year 2025 volume 56 Issue 8
58
7
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.08.016
  • Receive Date:2024-11-19
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2024-11-19
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.08.016
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT